Phase III Radium 223 mCRPC-PEACE III

NCT02194842 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

446

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Ra223
DRUG: Enzalutamide

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]